share_log

多瑞医药(301075.SZ)发前三季业绩,净亏损1707.87万元

Doray Pharmaceuticals (301075.SZ) released its performance for the first three quarters, with a net loss of 17.0787 million yuan.

Zhitong Finance ·  Oct 24, 2024 09:10

Doray Pharma (301075.SZ) released the third quarter report for the year 2024, during the reporting period the company achieved revenue...

Smart Finance APP News, Doray Pharma (301075.SZ) released the third quarter report for the year 2024, during the reporting period the company achieved revenue of 0.201 billion yuan, a decrease of 18.57% year-on-year; net loss attributable to shareholders of the listed company was 17.0787 million yuan; net loss after deducting non-recurring gains and losses attributable to shareholders of the listed company was 19.6861 million yuan; basic loss per share was 0.21 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment